148 related articles for article (PubMed ID: 32326334)
1. PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis.
Barbagallo F; Rotilio V; Assenza MR; Aguanno S; Orsini T; Putti S; Isidori AM; Lenzi A; Naro F; De Angelis L; Pellegrini M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326334
[TBL] [Abstract][Full Text] [Related]
2. Critical role of phosphodiesterase 2A in mouse congenital heart defects.
Assenza MR; Barbagallo F; Barrios F; Cornacchione M; Campolo F; Vivarelli E; Gianfrilli D; Auletta L; Soricelli A; Isidori AM; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2018 May; 114(6):830-845. PubMed ID: 29409032
[TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling.
Carlantoni C; Liekfeld LMH; Hemkemeyer SA; Schreier D; Saygi C; Kurelic R; Cardarelli S; Kalucka J; Schulte C; Beerens M; Mailer RK; Schäffer TE; Naro F; Pellegrini M; Nikolaev VO; Renné T; Frye M
Dev Cell; 2024 Feb; 59(3):308-325.e11. PubMed ID: 38159569
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cAMP/cGMP signaling as prevention of congenital heart defects in Pde2A deficient embryos: a matter of oxidative stress.
Cardarelli S; Biglietto M; Orsini T; Fustaino V; Monaco L; de Oliveira do Rêgo AG; Liccardo F; Masciarelli S; Fazi F; Naro F; De Angelis L; Pellegrini M
Cell Death Dis; 2024 Feb; 15(2):169. PubMed ID: 38395995
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lung phosphodiesterase 2A attenuates alveolar inflammation and protein leak in a two-hit mouse model of acute lung injury.
Rentsendorj O; Damarla M; Aggarwal NR; Choi JY; Johnston L; D'Alessio FR; Crow MT; Pearse DB
Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L161-70. PubMed ID: 21571906
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.
Rentsendorj O; D'Alessio FR; Pearse DB
J Leukoc Biol; 2014 Nov; 96(5):907-15. PubMed ID: 25063878
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species.
Stephenson DT; Coskran TM; Wilhelms MB; Adamowicz WO; O'Donnell MM; Muravnick KB; Menniti FS; Kleiman RJ; Morton D
J Histochem Cytochem; 2009 Oct; 57(10):933-49. PubMed ID: 19506089
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
Surapisitchat J; Jeon KI; Yan C; Beavo JA
Circ Res; 2007 Oct; 101(8):811-8. PubMed ID: 17704206
[TBL] [Abstract][Full Text] [Related]
10. A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors.
Wunder F; Gnoth MJ; Geerts A; Barufe D
Mol Pharm; 2009; 6(1):326-36. PubMed ID: 19049345
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A.
Módis K; Panopoulos P; Coletta C; Papapetropoulos A; Szabo C
Biochem Pharmacol; 2013 Nov; 86(9):1311-9. PubMed ID: 24012591
[TBL] [Abstract][Full Text] [Related]
12. Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.
Chen L; Cui S; Yu H; Li G; Liu N; Wu Q; Zhang HT; O'Donnell JM; Wang G; Xu Y
J Psychopharmacol; 2019 May; 33(5):568-576. PubMed ID: 30835157
[TBL] [Abstract][Full Text] [Related]
13. A Novel Inhibition Modality for Phosphodiesterase 2A.
Nakashima K; Matsui H
SLAS Discov; 2020 Jun; 25(5):498-505. PubMed ID: 32343157
[TBL] [Abstract][Full Text] [Related]
14. Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat.
Gu G; Scott T; Yan Y; Warren N; Zhang A; Tabatabaei A; Xu H; Aertgeerts K; Gomez L; Morse A; Li YW; Breitenbucher JG; Massari E; Vivian J; Danks A
J Pharmacol Exp Ther; 2019 Sep; 370(3):399-407. PubMed ID: 31253692
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of phosphodiesterase 2A in the submandibular gland of mice.
Adthapanyawanich K; Nakata H; Iseki S
Arch Oral Biol; 2018 Jun; 90():91-99. PubMed ID: 29597062
[TBL] [Abstract][Full Text] [Related]
16. SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis.
Watanabe T; Nakagawa K; Ohata S; Kitagawa D; Nishitai G; Seo J; Tanemura S; Shimizu N; Kishimoto H; Wada T; Aoki J; Arai H; Iwatsubo T; Mochita M; Watanabe T; Satake M; Ito Y; Matsuyama T; Mak TW; Penninger JM; Nishina H; Katada T
Dev Biol; 2002 Oct; 250(2):332-47. PubMed ID: 12376107
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing.
Kallenborn-Gerhardt W; Lu R; Bothe A; Thomas D; Schlaudraff J; Lorenz JE; Lippold N; Real CI; Ferreirós N; Geisslinger G; Del Turco D; Schmidtko A
Anesthesiology; 2014 Aug; 121(2):372-82. PubMed ID: 24758774
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
19. Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Chen L; Zhou J; Zhao Z; Zhu Y; Xing J; An J; Guo X
Cells; 2022 Dec; 12(1):. PubMed ID: 36611861
[TBL] [Abstract][Full Text] [Related]
20. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).
Trabanco AA; Buijnsters P; Rombouts FJ
Expert Opin Ther Pat; 2016 Aug; 26(8):933-46. PubMed ID: 27321640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
